- Home
- BOLT vs NXGL Comparison
BOLT vs NXGL Comparison
Compare BOLT & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- NXGL
- Stock Information
- Founded
- BOLT 2015
- NXGL 1997
- Country
- BOLT United States
- NXGL United States
- Employees
- BOLT N/A
- NXGL N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- BOLT Health Care
- NXGL Health Care
- Exchange
- BOLT Nasdaq
- NXGL Nasdaq
- Market Cap
- BOLT 16.8M
- NXGL 18.9M
- IPO Year
- BOLT 2021
- NXGL 2021
- Fundamental
- Price
- BOLT $0.37
- NXGL $2.70
- Analyst Decision
- BOLT Hold
- NXGL
- Analyst Count
- BOLT 5
- NXGL 0
- Target Price
- BOLT $1.13
- NXGL N/A
- AVG Volume (30 Days)
- BOLT 145.0K
- NXGL 36.7K
- Earning Date
- BOLT 05-13-2025
- NXGL 05-12-2025
- Dividend Yield
- BOLT N/A
- NXGL N/A
- EPS Growth
- BOLT N/A
- NXGL N/A
- EPS
- BOLT N/A
- NXGL N/A
- Revenue
- BOLT $7,690,000.00
- NXGL $8,688,000.00
- Revenue This Year
- BOLT N/A
- NXGL $51.39
- Revenue Next Year
- BOLT $77.45
- NXGL $36.14
- P/E Ratio
- BOLT N/A
- NXGL N/A
- Revenue Growth
- BOLT N/A
- NXGL 112.47
- 52 Week Low
- BOLT $0.30
- NXGL $1.84
- 52 Week High
- BOLT $1.34
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- BOLT 48.52
- NXGL 46.52
- Support Level
- BOLT $0.33
- NXGL $2.54
- Resistance Level
- BOLT $0.39
- NXGL $2.99
- Average True Range (ATR)
- BOLT 0.04
- NXGL 0.26
- MACD
- BOLT 0.00
- NXGL 0.01
- Stochastic Oscillator
- BOLT 66.06
- NXGL 62.43
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.